Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The Bioprotective Effects of Marigold Tea Polyphenols on Obesity and Oxidative Stress Biomarkers in High-Fat-Sugar Diet-Fed Rats

B. Alsuwayt, N. Iftikhar, AI. Hussain, A. Ahmad, I. Zafar, A. Khanam, WN. Tan, L. Nahar, AF. Almuqati, EM. Haji, AF. Almutairy, SD. Sarker

. 2024 ; 2024 (-) : 3833521. [pub] 20241004

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25010596

Background: The research is aimed at exploring the potential of marigold petal tea (MPT), rich in polyphenol contents, against oxidative stress and obesity in a rat model following a high-fat-sugar diet (HFSD). Methods: The MPT was prepared through the customary method of decoction and was subjected to analysis for its polyphenol composition using reversed-phase high-performance liquid chromatography (RP-HPLC). Two specific doses of MPT, namely, 250 and 500 mg/kg body weight (BW), were chosen for the study-referred to as MPT-250 and MPT-500, respectively. Result: The main phenolic acids and flavonoids identified in MPT, with concentrations exceeding 10 mg/100 mL of tea, included catechin, rutin, salicylic acid, gallic acid, sinapic acid, chlorogenic acid, cinnamic acid, and ellagic acid. The total phenolic (TP) and total flavonoid (TF) contents in MPT were measured to be 5.53 and 7.73 mg/g, respectively. Additionally, MPT demonstrated a 57.2% scavenging capacity with 2,2-diphenyl-1-picrylhydrazyl radical. Notably, the administration of a higher dose (MPT-500) showed a significant reduction in body mass index (BMI) and a 51.24% reduction in the rate of increase in BW compared to the HFSD group. The findings indicated that all the treatment groups, that is, orlistat treatment (OT), MPT-250, and MPT-500 groups, experienced reduced levels of serum total cholesterol (TC), triglyceride (TG), and markers of lipoproteins in contrast to the HFSD group. Moreover, MPT helped restore the levels of malondialdehyde (MDA), superoxide dismutase (SOD), and reduced glutathione (GSH), thereby demonstrating its potential in combating oxidative stress. The MPT-500 group also displayed decreased liver and kidney weights and an improved atherogenic index when compared to the HFSD group. Conclusion: The results clearly indicate that a high dosage of MPT showed antiobesity activity which was comparable to the same effects produced by the conventional drug orlistat.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25010596
003      
CZ-PrNML
005      
20250429135151.0
007      
ta
008      
250415e20241004enk f 000 0|eng||
009      
AR
024    7_
$a 10.1155/2024/3833521 $2 doi
035    __
$a (PubMed)39742004
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Alsuwayt, Bader $u Department of Pharmacy Practice, College of Pharmacy, University of Hafr Al Batin, Hafr Al Batin 39524, Saudi Arabia $1 https://orcid.org/0000000234357994
245    14
$a The Bioprotective Effects of Marigold Tea Polyphenols on Obesity and Oxidative Stress Biomarkers in High-Fat-Sugar Diet-Fed Rats / $c B. Alsuwayt, N. Iftikhar, AI. Hussain, A. Ahmad, I. Zafar, A. Khanam, WN. Tan, L. Nahar, AF. Almuqati, EM. Haji, AF. Almutairy, SD. Sarker
520    9_
$a Background: The research is aimed at exploring the potential of marigold petal tea (MPT), rich in polyphenol contents, against oxidative stress and obesity in a rat model following a high-fat-sugar diet (HFSD). Methods: The MPT was prepared through the customary method of decoction and was subjected to analysis for its polyphenol composition using reversed-phase high-performance liquid chromatography (RP-HPLC). Two specific doses of MPT, namely, 250 and 500 mg/kg body weight (BW), were chosen for the study-referred to as MPT-250 and MPT-500, respectively. Result: The main phenolic acids and flavonoids identified in MPT, with concentrations exceeding 10 mg/100 mL of tea, included catechin, rutin, salicylic acid, gallic acid, sinapic acid, chlorogenic acid, cinnamic acid, and ellagic acid. The total phenolic (TP) and total flavonoid (TF) contents in MPT were measured to be 5.53 and 7.73 mg/g, respectively. Additionally, MPT demonstrated a 57.2% scavenging capacity with 2,2-diphenyl-1-picrylhydrazyl radical. Notably, the administration of a higher dose (MPT-500) showed a significant reduction in body mass index (BMI) and a 51.24% reduction in the rate of increase in BW compared to the HFSD group. The findings indicated that all the treatment groups, that is, orlistat treatment (OT), MPT-250, and MPT-500 groups, experienced reduced levels of serum total cholesterol (TC), triglyceride (TG), and markers of lipoproteins in contrast to the HFSD group. Moreover, MPT helped restore the levels of malondialdehyde (MDA), superoxide dismutase (SOD), and reduced glutathione (GSH), thereby demonstrating its potential in combating oxidative stress. The MPT-500 group also displayed decreased liver and kidney weights and an improved atherogenic index when compared to the HFSD group. Conclusion: The results clearly indicate that a high dosage of MPT showed antiobesity activity which was comparable to the same effects produced by the conventional drug orlistat.
650    _2
$a zvířata $7 D000818
650    12
$a oxidační stres $x účinky léků $7 D018384
650    12
$a obezita $x farmakoterapie $x metabolismus $7 D009765
650    12
$a polyfenoly $x farmakologie $7 D059808
650    12
$a biologické markery $x krev $7 D015415
650    12
$a dieta s vysokým obsahem tuků $7 D059305
650    _2
$a mužské pohlaví $7 D008297
650    12
$a antioxidancia $x farmakologie $7 D000975
650    12
$a látky proti obezitě $x farmakologie $7 D019440
650    12
$a modely nemocí na zvířatech $7 D004195
650    _2
$a potkani Sprague-Dawley $7 D017207
650    _2
$a rostlinné extrakty $x farmakologie $x izolace a purifikace $7 D010936
650    _2
$a játra $x účinky léků $x metabolismus $7 D008099
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a sacharidová dieta $x škodlivé účinky $7 D000070601
650    _2
$a hmotnostní úbytek $x účinky léků $7 D015431
655    _2
$a časopisecké články $7 D016428
700    1_
$a Iftikhar, Neelam $u Department of Chemistry, Government College University Faisalabad, Faisalabad 38000, Pakistan
700    1_
$a Hussain, Abdullah Ijaz $u Department of Chemistry, Government College University Faisalabad, Faisalabad 38000, Pakistan $1 https://orcid.org/0000000178628859
700    1_
$a Ahmad, Ashfaq $u Department of Pharmacy Practice, College of Pharmacy, University of Hafr Al Batin, Hafr Al Batin 39524, Saudi Arabia $1 https://orcid.org/0000000291854639
700    1_
$a Zafar, Irsa $u Department of Chemistry, Government College University Faisalabad, Faisalabad 38000, Pakistan
700    1_
$a Khanam, Arifa $u Department of Chemistry, Government College University Faisalabad, Faisalabad 38000, Pakistan
700    1_
$a Tan, Wen-Nee $u Chemistry Section, School of Distance Education, Universiti Sains Malaysia, Penang 11800, Malaysia $1 https://orcid.org/0000000278123946
700    1_
$a Nahar, Lutfun $u Laboratory of Growth Regulators, Institute of Experimental Botany ASCR & Palacký University, Šlechtitelů 27 78371, Olomouc, Czech Republic
700    1_
$a Almuqati, Afaf F $u Department of Pharmaceutical Chemistry, College of Pharmacy, University of Hafr Al Batin, Hafr Al Batin 39524, Saudi Arabia $1 https://orcid.org/0000000243616791
700    1_
$a Haji, Esraa Mohammad $u Department of Pharmaceutical Chemistry, College of Pharmacy, University of Hafr Al Batin, Hafr Al Batin 39524, Saudi Arabia
700    1_
$a Almutairy, Ali F $u Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraydah 51452, Saudi Arabia $1 https://orcid.org/0009000779544893
700    1_
$a Sarker, Satyajit D $u Centre for Natural Products Discovery, School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, James Parsons Building, Byrom Street, Liverpool L3 3AF, UK $1 https://orcid.org/0000000340380514
773    0_
$w MED00173204 $t Cardiovascular therapeutics $x 1755-5922 $g Roč. 2024 (20241004), s. 3833521
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39742004 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429135146 $b ABA008
999    __
$a ok $b bmc $g 2311775 $s 1247677
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 2024 $c - $d 3833521 $e 20241004 $i 1755-5922 $m Cardiovascular therapeutics $n Cardiovasc Ther $x MED00173204
LZP    __
$a Pubmed-20250415

Najít záznam

Citační ukazatele

Možnosti archivace